Phenytoin Prodrugs III: Water-Soluble Prodrugs for Oral and/or Parenteral Use
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 73 (8) , 1068-1073
- https://doi.org/10.1002/jps.2600730812
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Pro-drugs as drug delivery systems VIII. Bioreversible derivatization of hydantoins by N-hydroxymethylationInternational Journal of Pharmaceutics, 1980
- Influence of dietary components on the bioavailability of phenytoin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out‐patients.British Journal of Clinical Pharmacology, 1979
- Solubility and Ionization Characteristics of PhenytoinJournal of Pharmaceutical Sciences, 1977
- Bioavailability of three phenytoin preparations in healthy subjects and in epilepticsEuropean Journal of Clinical Pharmacology, 1977
- BIOAVAILABILTY OF PHENYTOINThe Lancet, 1976
- Bioavailability of four brands of phenytoin tabletsEuropean Journal of Clinical Pharmacology, 1975
- Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoinEuropean Journal of Clinical Pharmacology, 1974
- Kinetics of Diphenylhydantoin Disposition in ManCHEMICAL & PHARMACEUTICAL BULLETIN, 1970
- Determination of the pKa' Value for 5,5-DiphenylhydantoinJournal of Pharmaceutical Sciences, 1968